Dr. Ajay Bapna Medical Oncologist

Doctor Overview

• Full Name & Designation: Dr. Ajay Bapna, Director & Head of Department (HOD), Medical Oncology
• Specialisation(s): Medical Oncology, Paediatric Oncology, Haematology
• Years of Experience: 29+ years
• Current Hospital/Institution Affiliation: Bhagwan Mahaveer Cancer Hospital & Research Centre (BMCHRC), Jaipur

Dr. Ajay Bapna is a highly experienced and respected Medical Oncologist. With over 29 years of dedicated practice in oncology, Dr. Bapna played a pivotal role in establishing the Medical Oncology department at BMCHRC. He holds an MD in Internal Medicine and specialised further with a DM in Medical Oncology from the renowned Tata Memorial Hospital, Mumbai. Dr. Bapna’s expertise encompasses a wide range of cancer treatments, with special interests in immunotherapy, targeted therapy, and chemotherapy, alongside Paediatric Oncology and Haematology. He is known for his meticulous approach to diagnosis and his empathetic care for patients. An active member of key oncology societies like ASCO and ISMPO, Dr. Bapna remains at the forefront of cancer research and treatment advancements.

Qualifications & Credentials

Medical Degrees:

• MBBS: Sawai Man Singh Medical College, Jaipur
• MD (Internal Medicine): Sawai Man Singh Medical College, Jaipur
• DM (Medical Oncology): Tata Memorial Center / Tata Memorial Hospital, Mumbai

Fellowships & Special Training:

• Specialised Oncology training at Tata Memorial Hospital, Mumbai

Areas of Expertise

Major Cancer Types Treated:

• Lung Cancer
• Breast Cancer
• Head and Neck Cancer
• Ovarian Cancer & other Gynaecological Cancers
• Gastrointestinal Cancers (Oesophageal, Stomach, Small Intestine, Colon)
• Haematological Malignancies (Leukaemia, Lymphoma, Multiple Myeloma)
• Genitourinary Cancers
• Adrenal Gland Cancer
• Liver Cancer
• Paediatric Cancers
• Thyroid Cancer
• Mouth Cancer

Sub-specialties:

• Medical Oncology
• Paediatric Oncology
• Haematology

Advanced Procedures Performed:

• Chemotherapy
• Immunotherapy
• Targeted Therapy
• Hormonal Therapy

Professional Experience

Current & Past Hospital Affiliations:

• Director & HOD, Department of Medical Oncology – Bhagwan Mahaveer Cancer Hospital & Research Centre (BMCHRC), Jaipur (Present)

Academic & Research Roles:

• Actively involved in research work and various workshops within Medical Oncology.
• Authored and co-authored numerous papers published in national and international journals.
• Participates in clinical research and stays updated through professional memberships.

Key Achievements & Contributions:

• Founding member and establisher of the Department of Medical Oncology at BMCHRC (1998).

Awards & Recognitions

National & International Awards:

• Dainik Bhaskar Healthcare Award 2021 (Excellence in Oncology, Jaipur)

Recognitions & Honors:

• Member: Indian Cooperative Oncology Network (ICON)
• Member: Indian Society of Medical and Paediatric Oncology (ISMPO)
• Member: American Society of Clinical Oncology (ASCO).

Research & Publications

Published Papers in Medical Journals:

• Genetic Counselling, Testing, and Management of Hereditary Breast and Ovarian Cancer Syndrome in India: Updated Expert Consensus Recommendations from Indian Society of Medical and Pediatric Oncology. Indian Journal of Medical and Paediatric Oncology (March 2025 – Note: Future date as per source)
• Real-World Evidence of the Impact of CanAssist Breast on Physician’s Decision About the Use of Adjuvant Chemotherapy in Early Breast Cancer. Cureus (December 2024 – Note: Future date as per source)
• Risk Stratification of Early Breast Cancer (HR +/HER 2–) by CanAssist Breast and Its Corelation with Other Online Prognostic Tools: Experience from a Single Center. Indian Journal of Medical and Paediatric Oncology (August 2023)
• Impact of cost of Oncotype DX versus CanAssist Breast, an Indian prognostic test, in the management of node-negative early breast cancer in a single centre in India. JCO Global Oncology (August 2023)
• Consensus guidelines for the management of HR-positive HER2/neu negative early breast cancer in India, SAARC region and other LMIC by DELPHI survey method. BMC Cancer (July 2023)
• The Role of Bosutinib in Chronic Myeloid Leukemia: An Indian Perspective. Indian Journal of Medical and Paediatric Oncology (November 2022)
• A prospective single arm study evaluating the outcome of neoadjuvant chemotherapy in locally advanced/border line resectable gall bladder cancer. Annals of Oncology (November 2022)
• A single centre study from western India to evaluate the frequency of developing second and subsequent multiple primary malignancies among cancer survivors. Surgical and Experimental Pathology (September 2022)
• An Investigator-Initiated Study of Gemcitabine and Capecitabine in Indian Patients with Unresectable or Metastatic Gallbladder Cancer. Oncology Journal of India (May 2022)
• Outcome in patients of hormone receptor (HR) positive (Her 2) negative metastatic breast cancer treated with palbociclib – A real-world experience. International Journal of Molecular and Immuno Oncology (January 2022)

Patient Success Stories & Testimonials

“Dr. Ajay Bapna’s experience truly shows. He explained my chemotherapy plan thoroughly and managed my treatment with great care and expertise. His empathetic approach made a difficult time more manageable.” – R. Sharma

“We consulted Dr. Bapna for immunotherapy. He is very knowledgeable and up-to-date with the latest treatments. We felt confident under his care, and his team was excellent.” – S. Agarwal

“As the Director, Dr. Bapna leads a fantastic department. He diagnosed my condition accurately and treated me with compassion. Highly recommended for anyone seeking expert cancer care in Jaipur.” – K. Singh

Treatment Approach & Philosophy

• Patient-Centred Care: Dr. Bapna is known for his focus on accurate diagnosis and providing empathetic treatment. He tailors care plans to individual patient needs, ensuring clarity and support throughout the treatment process. He is fluent in English, Hindi, and Rajasthani, facilitating effective communication.
• Technology & Innovation: Dr. Bapna actively incorporates modern advancements in medical oncology, including Immunotherapy and Targeted Therapy, alongside traditional Chemotherapy. His membership in international societies like ASCO and his research involvement reflect his commitment to evidence-based medicine and utilising innovative approaches for better patient outcomes.

Consultation Fees & Treatment Costs

You can schedule an Dr. Ajay Bapna Jaipur consultationby contacting the Cancer Rounds team.

Costs for medical oncology treatments vary widely based on the specific drugs used (chemotherapy agents, immunotherapy drugs, targeted therapies), duration of treatment, required supportive care, and hospital charges. Cancer Rounds can provide assistance in obtaining estimated treatment costs. Below are indicative ranges:

Disclaimer: These are indicative estimates. Actual costs vary based on individual treatment protocols, drug brands, hospital tariffs, and patient-specific factors. Consult the Cancer Rounds team for detailed cost information.

International Patient Assistance

• Language Support: Dr. Bapna is fluent in English, Hindi, and Rajasthani. Cancer Rounds can assist in arranging interpreter services for other languages if needed by international patients.
• Visa & Travel Assistance: Cancer Rounds supports international patients with medical visa facilitation, travel planning, airport transfers, and identifying suitable accommodation options..
• Pre-treatment Virtual Consultations: Cancer Rounds can help coordinate remote second opinions or initial virtual consultations with Dr. Ajay Bapna, allowing international patients to discuss their case and treatment options before travelling to India.

FAQs

Q 1. How many years of experience does Dr. Bapna have?

Dr. Ajay Bapna possesses over 29 years of extensive experience in the field of Medical Oncology.

Q 2. What specific treatments does Dr. Bapna specialise in?

Dr. Bapna, Best Cancer Doctor in Jaipur specialises in administering Chemotherapy, Immunotherapy, and Targeted Therapy. He treats a wide variety of solid tumours and haematological malignancies in both adults and children.

Q 3. What are Dr. Ajay Bapna’s key achievements?

Dr. Ajay Bapna key achievements include establishing the Medical Oncology department at BMCHRC in 1998, holding the position of Director & HOD, receiving the Dainik Bhaskar Healthcare Award (2021), and having a long, reputable career with numerous publications.

Q 4. Is Dr. Ajay Bapna involved in cancer research?

Dr. Bapna is actively involved in research, has published numerous papers in national and international journals, and is a member of leading oncology societies like ASCO and ISMPO, indicating his commitment to research and evidence-based practice.

Q 5. How can I book an appointment with Dr. Ajay Bapna?

You can book Dr. Ajay Bapna medical oncologist appointment directly through Cancer Rounds. The team will assist you with scheduling appointments, coordinating consultations, and providing support services for a smoother experience